Neither mebendazole nor albendazole.

If neither medical science nor PAIR therapy is an action, medical therapy with albendazole is administered (mebendazole is an alternative that is considered less effective). Albendazole is given as a 400 mg dose twice a day for 28 days, often with additional 28-day courses given in subsequent months, with each class separated by 14-day treatment-free periods.125 Most commonly, albendazole therapy is continued for 6 months. Patients need to be monitored for complications during long-term albendazole therapy, because hepatotoxicity, symptom, and neutropenia are common. Neither mebendazole nor albendazole is completely effective: 20% to 40% of patients happening no transformation. Albendazole therapy results in a cure in about one simple fraction of patients and leads to regress in cyst size and transmutation in symptoms in another gear. Both agents are contraindicated during pregnancy. Periodical titers of echinococcal antibodies can be useful in monitoring therapeutic mortal.